Results 141 to 150 of about 166,203 (279)
ABSTRACT Background Tapinarof cream 1%, a non‐steroidal topical aryl hydrocarbon receptor‐modulating agent, is approved in Japan for atopic dermatitis (AD) and plaque psoriasis. Real‐world data on longitudinal outcomes, treatment continuation, interruption and restart, and adverse‐event timing are limited. Methods This single‐center retrospective study
Kanade Iino +2 more
wiley +1 more source
ABSTRACT Vitiligo, a common and chronic depigmentation disorder, significantly impacts patients' quality of life and exerts a substantial economic burden. The deleterious impact of vitiligo can be exacerbated by comorbid conditions, including psychiatric and autoimmune conditions.
Naoki Oiso +9 more
wiley +1 more source
Tacrolimus ointment in the management of atopic dermatitis
Antonello Baldo, Mariana Cafiero, Paola Di Caterino, Luisa Di CostanzoDepartment of Dermatology, University of Naples Federico II, Naples, ItalyAbstract: Atopic dermatitis (AD) is a chronic, relapsing, highly pruritic inflammatory skin disease.
Paola Di Caterino +3 more
core
Allergen immunotherapy in atopic dermatitis
The aim of this review is to investigate the possible role of allergen immunotherapy (AIT) for house dust mites in the treatment of atopic dermatitis in adult patients (AD).
Andrzej Bożek +1 more
core +1 more source
Contact Allergens Relevant to LGBTQI Populations: A Narrative Review and Practical Considerations
ABSTRACT Allergic contact dermatitis (ACD) is a common inflammatory skin disorder with significant morbidity across populations. Sexual and gender minority (SGM) individuals, including LGBTQI populations, are exposed to unique allergens due to gender‐affirming medical therapies, surgical interventions, cosmetics and grooming practices, sexual health ...
Nicholas van Rooij
wiley +1 more source
Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series
ABSTRACT We present three patients who developed allergic contact dermatitis (ACD) from benzalkonium chloride (BAK) in ophthalmic drops. BAK is a preservative commonly found in ophthalmic formulations and there is a rising trend of ACD to this allergen. The irritant and sensitising properties of BAK on the ocular mucosa will be discussed.
Arav Kannen +2 more
wiley +1 more source
ABSTRACT Dupilumab‐associated erythema multiforme and lichenoid eruptions have been previously reported as rare dermatological adverse events. We present an atypical paediatric case of a dupilumab‐associated erythema multiforme‐like eruption in a 5‐year‐old male eczema patient, who developed erythematous targetoid papules and plaques over the upper and
Paul Sun Woo Kim +7 more
wiley +1 more source
A Subcellular Keap1-Nrf2 Disruption Strategy for Atopic Dermatitis Therapy. [PDF]
Zhang Z +7 more
europepmc +1 more source

